Advanced search
Publication Cover
Bioscience, Biotechnology, and Biochemistry Volume 75, 2011 - Issue 9
Journal homepage
518
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

An Efficient and Novel Screening Model for Assessing the Bioactivity of Extracts against Multidrug-Resistant Pseudomonas aeruginosa Using Caenorhabditis elegans

Yu-meng ZHOUState Key Lab for New Drug and Pharmaceutical Processes, Shanghai Institute of Pharmaceutical Industry
,
Lei SHAOState Key Lab for New Drug and Pharmaceutical Processes, Shanghai Institute of Pharmaceutical Industry
,
Ji-an LIState Key Lab for New Drug and Pharmaceutical Processes, Shanghai Institute of Pharmaceutical Industry
,
Li-zhong HANShanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine
,
Wai-jiao CAIInstitute for Integrative Chinese and Western Medicine, Huashan Hospital, Fuden University
,
Chun-bao ZHUState Key Lab for New Drug and Pharmaceutical Processes, Shanghai Institute of Pharmaceutical Industry
&
Dai-jie CHENState Key Lab for New Drug and Pharmaceutical Processes, Shanghai Institute of Pharmaceutical Industry
 show all
Pages 1746-1751 | Received 12 Apr 2011, Accepted 16 Jun 2011, Published online: 22 May 2014

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Maged Muhammed, Marios Arvanitis & Eleftherios Mylonakis. (2016) Whole animal HTS of small molecules for antifungal compounds. Expert Opinion on Drug Discovery 11:2, pages 177-184.
Read now

Articles from other publishers (19)

Haowen Zhao, Yuhao Ren, Feng Xie, Huanqin Dai, Hongwei Liu, Chengzhang Fu & Rolf Müller. (2023) Nobachelins, new siderophores from Nocardiopsis baichengensis protecting Caenorhabditis elegans from Pseudomonas aeruginosa infection. Synthetic and Systems Biotechnology 8:4, pages 640-646.
Crossref
Samah H. O. Zarroug, Juhaina S. Bajaman, Fatheia N. Hamza, Rimah A. Saleem & Hana K. Abdalla. (2023) Caenorhabditis elegans as an In Vivo Model for the Discovery and Development of Natural Plant-Based Antimicrobial Compounds. Pharmaceuticals 16:8, pages 1070.
Crossref
Bowen Tang & Vijay More. (2023) Recent Advances in Drug Discovery Toxicology. International Journal of Toxicology.
Crossref
Juntao Zhang, Yanmei Zhao, Zhihong Sun & Tiansong Sun. (2022) Lacticaseibacillus rhamnosus Probio-M9 extends the lifespan of Caenorhabditis elegans. Communications Biology 5:1.
Crossref
Sebastián Giunti, Natalia Andersen, Diego Rayes & María José De Rosa. (2021) Drug discovery: Insights from the invertebrate Caenorhabditis elegans . Pharmacology Research & Perspectives 9:2.
Crossref
Xing Jin, Yufeng He, Zhenmin Liu, Yonghua Zhou, Xiaohua Chen, Gang Wang, Zhihong Sun, Jianxin Zhao, Hao Zhang & Wei Chen. (2020) Lactic acid bacteria exhibit similar antioxidant capacities in Caenorhabditis elegans - and Campylobacter jejuni -infected mice . RSC Advances 10:6, pages 3329-3342.
Crossref
Kitlangki Suchiang & Ramatchandirane Mahesh. 2020. Model Organisms for Microbial Pathogenesis, Biofilm Formation and Antimicrobial Drug Discovery. Model Organisms for Microbial Pathogenesis, Biofilm Formation and Antimicrobial Drug Discovery 559 596 .
Patricia S. Pardo & Katherina Walz. 2019. Cellular and Animal Models in Human Genomics Research. Cellular and Animal Models in Human Genomics Research 49 68 .
Jianping Yang, Meiqiong Zheng, Fan Yang, Xiulian Zhang, Wei Yin, Xiaojun Liu, Guo-Jun Zhang & Zuanguang Chen. (2018) Pseudomonas aeruginosa infected nematode-on-a-chip model array for antibacterials screening. Sensors and Actuators B: Chemical 275, pages 373-381.
Crossref
Siti N. Fatin, Tan Boon-Khai, Alexander Chong Shu-Chien, Melati Khairuddean & Amirul Al-Ashraf Abdullah. (2017) A Marine Actinomycete Rescues Caenorhabditis elegans from Pseudomonas aeruginosa Infection through Restitution of Lysozyme 7. Frontiers in Microbiology 8.
Crossref
Bo Fu, Qiaolian Wu, Minyan Dang, Dangdang Bai, Qiao Guo, Lixin Shen & Kangmin Duan. (2017) Inhibition of Pseudomonas aeruginosa Biofilm Formation by Traditional Chinese Medicinal Herb Herba patriniae . BioMed Research International 2017, pages 1-10.
Crossref
Cin Kong, Su-Anne Eng, Mei-Perng Lim & Sheila Nathan. (2016) Beyond Traditional Antimicrobials: A Caenorhabditis elegans Model for Discovery of Novel Anti-infectives. Frontiers in Microbiology 7.
Crossref
Silvia Maglioni, Nayna Arsalan & Natascia Ventura. (2016) C. elegans screening strategies to identify pro-longevity interventions. Mechanisms of Ageing and Development 157, pages 60-69.
Crossref
Linda P. O'Reilly, Cliff J. Luke, David H. Perlmutter, Gary A. Silverman & Stephen C. Pak. (2014) C. elegans in high-throughput drug discovery. Advanced Drug Delivery Reviews 69-70, pages 247-253.
Crossref
Marios Arvanitis, Justin Glavis-Bloom & Eleftherios Mylonakis. (2013) C. elegans for anti-infective discovery. Current Opinion in Pharmacology 13:5, pages 769-774.
Crossref
Curtis J. Henrich & John A. Beutler. (2013) Matching the power of high throughput screening to the chemical diversity of natural products. Natural Product Reports 30:10, pages 1284.
Crossref
Jianping Yang, Zuanguang Chen, Poying Ching, Qiujia Shi & Xinchun Li. (2013) An integrated microfluidic platform for evaluating in vivo antimicrobial activity of natural compounds using a whole-animal infection model. Lab on a Chip 13:17, pages 3373.
Crossref
Gianfranco Grompone, Patricia Martorell, Silvia Llopis, Núria González, Salvador Genovés, Ana Paula Mulet, Tamara Fernández-Calero, Inés Tiscornia, Mariela Bollati-Fogolín, Isabelle Chambaud, Benoit Foligné, Agustín Montserrat & Daniel Ramón. (2012) Anti-Inflammatory Lactobacillus rhamnosus CNCM I-3690 Strain Protects against Oxidative Stress and Increases Lifespan in Caenorhabditis elegans. PLoS ONE 7:12, pages e52493.
Crossref
S. Brul, J. Bassett, P. Cook, S. Kathariou, P. McClure, P.R. Jasti & R. Betts. (2012) ‘Omics’ technologies in quantitative microbial risk assessment. Trends in Food Science & Technology 27:1, pages 12-24.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.